The association of CDKN2BAS gene polymorphisms and intracranial aneurysm: A meta-analysis

Medicine (Baltimore). 2020 Dec 4;99(49):e23209. doi: 10.1097/MD.0000000000023209.

Abstract

Intracranial aneurysm (IA) is one of the main causes of subarachnoid hemorrhage (SAH) leading to a high percentage of disability and mortality worldwide. In addition to environmental factors, the risk of rupture or prognosis of intracranial aneurysm is also closely related to gene. Thus, a lot of genetic studies have been used to explore associated risk genes as well as variant loci of intracranial aneurysm and found several chromosome variates including 9p21.3 (CDKN2BAS) related to Intracranial aneurysm. However, due to differences in population and the existence of SNP, it is still not determined that whether these genetic changes can be identified as independent risk factors for intracranial aneurysm. Therefore, we performed a meta-analysis of CDKN2BAS SNPs to explore its association with intracranial aneurysms and the results show a significance relation between rs10757272, rs1333040, and rs6475606 with intracranial aneurysm. This will open a new perspective for future intracranial aneurysm gene research and therapy.

Publication types

  • Meta-Analysis

MeSH terms

  • Cyclin-Dependent Kinase Inhibitor p15 / genetics*
  • Humans
  • Intracranial Aneurysm / genetics*
  • Polymorphism, Single Nucleotide
  • RNA, Long Noncoding / genetics*

Substances

  • CDKN2B antisense RNA, human
  • CDKN2B protein, human
  • Cyclin-Dependent Kinase Inhibitor p15
  • RNA, Long Noncoding